EUVIMEDObjevte EUVIMED
Open access · CC BY 4.0

Tumor Invasive Border Index ( TIBI ) in colorectal cancer: linking infiltrative morphology to molecular insights

Akseli Kehusmaa iD, Jouni Härkönen, Huayi Li, Päivi Sirniö, Ville K Äijälä iD, Henna Karjalainen, Meeri Kastinen, Vilja V Tapiainen, Tuomo Mantere, Vesa-Matti Pohjanen, Hanna Elomaa, Onni Sirkiä and 18 more

The Journal of Pathology · 2026

DOI: 10.1002/path.70087 ↗

At a glance

Journal article in The Journal of Pathology, 2026. Written by Akseli Kehusmaa and 29 co-authors. Institution: Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland. Major MEDLINE topics: Colorectal Neoplasms, Biomarkers, Tumor. Cited 2 times so far (Crossref); 52 references. The full text is freely available (open access, CC BY 4.0). Funded by: Oulun Yliopiston Tukisäätiö, Kaarina and Erkki Piippola Foundation, Cancer Foundation of Northern Finland.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Tumor border configuration influences colorectal cancer (CRC) prognosis, yet its molecular determinants remain unclear and existing assessment criteria have faced challenges with reproducibility. We introduce the Tumor Invasive Border Index (TIBI), a novel and reproducible method that quantifies the proportion of tumor stroma and adipose tissue within a hotspot at the deepest point of invasion. TIBI was evaluated in two CRC cohorts ( n = 1,100 and n = 776) and analyzed in relation to tumor and patient features. Molecular correlates of an infiltrative growth pattern were explored in The Cancer Genome Atlas (TCGA) CRC cohorts ( n = 350), with key features validated independently. High TIBI, indicating an infiltrative border, was associated with advanced disease, tumor budding, lymphovascular invasion, and an immune microenvironment characterized by lower M1‐like macrophage and granulocyte densities. High TIBI independently predicted higher CRC‐specific mortality, with multivariable hazard ratios of 1.52 (95% CI 1.07–2.17) in cohort 1 and 2.45 (95% CI 1.37–4.37) in cohort 2. Molecular analysis revealed associations with mismatch repair proficiency, TP53 and KRAS mutations, MYC signaling downregulation, and epithelial‐mesenchymal transition upregulation. L1CAM and DSG3 were among the genes showing high expression in infiltrative tumors. As experimental validation, we identified a CRC cell line with high expression of L1CAM and DSG3 and demonstrated that silencing them reduced invasion in vitro . A TIBI‐associated gene signature also predicted infiltrative growth and adverse outcome in the TCGA gastric cancer cohort. These findings highlight molecular characteristics of tumor border configuration and establish TIBI as a clinically relevant tumor biomarker. © 2026 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Colorectal NeoplasmsBiomarkers, TumorHumansNeoplasm InvasivenessTumor MicroenvironmentFemaleMaleEpithelial-Mesenchymal TransitionMiddle AgedAgedPrognosisAdipose TissueMutationPredictive Value of Tests

Author keywords

colorectal cancerepithelial‐mesenchymal transitiontumor biomarkerstumor border configurationtumor invasion

Substances

Biomarkers, Tumor

Authors and institutions

  • Translational Medicine Research Unit, Medical Research Center Oulu, Oulu University Hospital, and University of Oulu, Oulu, Finland.
  • Department of Pathology, Hospital Nova of Central Finland, Well Being Services County of Central Finland, Jyväskylä, Finland.
  • Faculty of Health Sciences, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku, Finland.
  • Research Program in Systems Oncology, University of Helsinki, Helsinki, Finland.
  • Department of Environmental and Biological Sciences, University of Eastern Finland, Kuopio, Finland.

ORCID profiles: Akseli Kehusmaa, Ville K Äijälä, Toni T Seppälä, Juha P Väyrynen

Funding

  • Oulun Yliopiston Tukisäätiö
  • Kaarina and Erkki Piippola Foundation
  • Cancer Foundation of Northern Finland
  • Orionin Tutkimussäätiö
  • Sigrid Juséliuksen Säätiö
  • Finnish State Research Funding
  • Syöpäsäätiö
  • Suomen Lääketieteen Säätiö

Cite

APA

Kehusmaa, A., Härkönen, J., Li, H., Sirniö, P., Äijälä, V. K., Karjalainen, H., Kastinen, M., Tapiainen, V. V., Mantere, T., Pohjanen, V. M., Elomaa, H., Sirkiä, O., Pasquier, N., Ahtiainen, M., Helminen, O., Wirta, E. V., Mattila, T. T., Lindgren, O., Savela, J., …, & Väyrynen, J. P. (2026). Tumor Invasive Border Index ( TIBI ) in colorectal cancer: linking infiltrative morphology to molecular insights. The Journal of Pathology. https://doi.org/10.1002/path.70087

Vancouver

Kehusmaa A, Härkönen J, Li H, Sirniö P, Äijälä VK, Karjalainen H, et al. Tumor Invasive Border Index ( TIBI ) in colorectal cancer: linking infiltrative morphology to molecular insights. The Journal of Pathology. 2026. doi:10.1002/path.70087

BibTeX
@article{Kehusmaa2026,
  author = {Kehusmaa, Akseli and Härkönen, Jouni and Li, Huayi and Sirniö, Päivi and Äijälä, Ville K and Karjalainen, Henna and Kastinen, Meeri and Tapiainen, Vilja V and Mantere, Tuomo and Pohjanen, Vesa-Matti and Elomaa, Hanna and Sirkiä, Onni and Pasquier, Nicolas and Ahtiainen, Maarit and Helminen, Olli and Wirta, Erkki-Ville and Mattila, Taneli T and Lindgren, Outi and Savela, Janette and Rintala, Jukka and Meriläinen, Sanna and Saarnio, Juha and Rautio, Tero and Seppälä, Toni T and Böhm, Jan and Mecklin, Jukka-Pekka and Mäkinen, Markus J and Tuomisto, Anne and Ivaska, Johanna and Väyrynen, Juha P},
  title = {Tumor Invasive Border Index ( TIBI ) in colorectal cancer: linking infiltrative morphology to molecular insights},
  journal = {The Journal of Pathology},
  year = {2026},
  doi = {10.1002/path.70087}
}
Start for free →